MOTIVATION: Robust computer algorithms are required to interpret the vast amounts of proteomic data currently being produced and to generate generalized models which are applicable to 'real world' scenarios. One such scenario is the classification of bacterial species. These vary immensely, some remaining remarkably stable whereas others are extremely labile showing rapid mutation and change. Such variation makes clinical diagnosis difficult and pathogens may be easily misidentified. RESULTS: We applied artificial neural networks (Neuroshell 2) in parallel with cluster analysis and principal components analysis to surface enhanced laser desorption/ionization (SELDI)-TOF mass spectrometry data with the aim of accurately identifying the bacterium Neisseria meningitidis from species within this genus and other closely related taxa. A subset of ions were identified that allowed for the consistent identification of species, classifying >97% of a separate validation subset of samples into their respective groups. AVAILABILITY: Neuroshell 2 is commercially available from Ward Systems.
MOTIVATION: Robust computer algorithms are required to interpret the vast amounts of proteomic data currently being produced and to generate generalized models which are applicable to 'real world' scenarios. One such scenario is the classification of bacterial species. These vary immensely, some remaining remarkably stable whereas others are extremely labile showing rapid mutation and change. Such variation makes clinical diagnosis difficult and pathogens may be easily misidentified. RESULTS: We applied artificial neural networks (Neuroshell 2) in parallel with cluster analysis and principal components analysis to surface enhanced laser desorption/ionization (SELDI)-TOF mass spectrometry data with the aim of accurately identifying the bacterium Neisseria meningitidis from species within this genus and other closely related taxa. A subset of ions were identified that allowed for the consistent identification of species, classifying >97% of a separate validation subset of samples into their respective groups. AVAILABILITY: Neuroshell 2 is commercially available from Ward Systems.
Authors: Kah Hoong Chang; Nicola Miller; Elrasheid A H Kheirelseid; Christophe Lemetre; Graham R Ball; Myles J Smith; Mark Regan; Oliver J McAnena; Michael J Kerin Journal: Int J Colorectal Dis Date: 2011-07-08 Impact factor: 2.571
Authors: Brooks B Gump; James A MacKenzie; Amy K Dumas; Christopher D Palmer; Patrick J Parsons; Zaneer M Segu; Yehia S Mechref; Kestutis G Bendinskas Journal: Environ Res Date: 2011-10-24 Impact factor: 6.498
Authors: Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; John Newell; Christophe Lemetre; Graham Balls; Michael J Kerin Journal: Int J Colorectal Dis Date: 2012-08-18 Impact factor: 2.571
Authors: Manal Helal; Fanrong Kong; Sharon C A Chen; Michael Bain; Richard Christen; Vitali Sintchenko Journal: PLoS One Date: 2011-06-08 Impact factor: 3.240
Authors: Dong L Tong; David J Boocock; Clare Coveney; Jaimy Saif; Susana G Gomez; Sergio Querol; Robert Rees; Graham R Ball Journal: Clin Proteomics Date: 2011-09-19 Impact factor: 3.988
Authors: Aoife J Lowery; Nicola Miller; Amanda Devaney; Roisin E McNeill; Pamela A Davoren; Christophe Lemetre; Vladimir Benes; Sabine Schmidt; Jonathon Blake; Graham Ball; Michael J Kerin Journal: Breast Cancer Res Date: 2009-05-11 Impact factor: 6.466